news Smart insulin patch could make painful injections a thing of the past for diabetes sufferers 23 June 2015 | By Victoria White Researchers have created the first smart insulin patch that can detect increases in blood sugar levels and secrete doses of insulin into the bloodstream...
news Sanofi reports positive Phase 3 results for Toujeo® 19 June 2014 | By Sanofi Sanofi announced that, in a pooled analysis, investigational therapy Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL) consistently showed significantly fewer low blood sugar events (hypoglycemia)...
news Jardiance® (empagliflozin) as an add-on therapy significantly reduced blood glucose and body weight in two newly presented Phase III trials 17 June 2014 | By Boehringer Ingelheim Boehringer Ingelheim and Eli Lilly and Company presented results of two Phase III clinical trials studying the efficacy and safety of empagliflozin...
news New phase 3 study shows efficacy and safety of Victoza® for the treatment of type 2 diabetes in adults with moderate renal impairment 16 June 2014 | By Novo Nordisk Data from a new phase 3 study demonstrated that once-daily Victoza® (liraglutide) provided greater glycaemic control versus placebo with no worsening of renal function in adults with type 2 diabetes and moderate renal impairment...